Conmed (CNMD) Shares Outstanding (Diluted Average) (2010 - 2026)
Conmed (CNMD) reported Shares Outstanding (Diluted Average) of $30.6 million for Q1 2026, down 1.7% on a YoY basis from $31.2 million in Q1 2025, and down 1.38% quarter-over-quarter from $31.0 million in Q3 2025.
Conmed (CNMD) Shares Outstanding (Diluted Average) (2010 - 2026) Analysis & Trends
Conmed has reported Shares Outstanding (Diluted Average) for 17 years, with the latest figure at $30.6 million in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.75 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 386.50 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.29 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.50 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 580.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 393.60 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 457.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | - |
| 10 | Conmed | 994.72 Mn | 959.69 Mn | 183.45 Mn | 30.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 30.62 Mn |
| Sep 30, 2025 | 31.05 Mn |
| Jun 30, 2025 | 31.05 Mn |
| Mar 31, 2025 | 31.15 Mn |
| Sep 30, 2024 | 31.11 Mn |
| Jun 30, 2024 | 31.11 Mn |
| Mar 31, 2024 | 31.27 Mn |
| Sep 30, 2023 | 31.69 Mn |
| Jun 30, 2023 | 31.80 Mn |
| Mar 31, 2023 | 31.20 Mn |
| Sep 30, 2022 | 29.89 Mn |
| Jun 30, 2022 | 29.60 Mn |
| Mar 31, 2022 | 35.16 Mn |
| Sep 30, 2021 | 32.14 Mn |
| Jun 30, 2021 | 31.96 Mn |
| Mar 31, 2021 | 31.38 Mn |
| Sep 30, 2020 | 28.53 Mn |
| Jun 30, 2020 | 28.51 Mn |
| Mar 31, 2020 | 29.71 Mn |
| Sep 30, 2019 | 29.35 Mn |